Tag
psychedelics industry
- FDA psychedelics hearing draws little pushback on future therapeutic use
- Puerto Rico governor signs executive order for psychedelic therapy research
- San Francisco college to offer world's first undergraduate psychedelics degree
- Filament Health secures investment to remedy concerning financial position
- COMPASS Pathways reports 52% YoY cash loss
- Optimi Health enters $1.2M psilocybin distribution agreement
- Psyched Wellness Amanita muscaria extract shows potential for brain health improvement
- University of Exeter launches postgrad psychedelics certificate program
- Reunion Neuroscience struggles to maintain Nasdaq listing requirements
- International psychedelics market to reach US$8.3B by 2027: ReportLinker
- Mydecine's MDMA with rapid onset and a short duration shows promising results
- LSD helps alleviate anxiety and major depression symptoms: MindMed
- MGC Pharma gets permission from Slovenian health authorities to research psilocybin
- Dutch government establishes MDMA research commission
- Psilocybin access denied to patients despite ongoing lawsuit against Health Canada
- Lucy Scientific and Wesana Health partner to develop CBD and psilocybin-based drug
- Optimi Health secures MDMA and psilocybin distribution agreement in Australia
- Awakn Life Sciences helps establish psychedelics clinics in Portugal
- Lucy Scientific Discovery applies for Health Canada approval to produce cocaine and heroin
- Psyched Wellness formulates first commercial Amanita muscaria extract
- Optimi Health submits clinical trial application after developing proprietary MDMA drug
- Woke Pharma and Swinburne U partner for Australia's biggest psilocybin trial
- PharmAla Biotech gets Health Canada approval to export large MDMA shipment to the U.K.
- Apex Labs doses first patient in Veterans take-home psilocybin drug trial
- Biomind Labs develops sublingual psychedelic drug to treat Alzheimer's
- Awakn set to research ketamine for alcohol use disorder
- Health Canada provides guidance for clinical trials on psychedelics
- U.S. senators introduce bill to improve access to psilocybin and MDMA
- PharmAla and Mindset enter psilocybin distribution agreement
- Mindset Pharma develops patent-pending new technology
- MagicMed attracts investors to advance library of psychedelic derivatives